Top Markets
Coin of the day
Addex Therapeutics Ltd Addex Therapeutics Ltd

Addex Therapeutics Ltd

ADXN
Helyezés a részvények között #33372
Addex Therapeutics Ltd, a biopharmaceutical company in its development phase,... Addex Therapeutics Ltd, a biopharmaceutical company in its development phase, specializes in the discovery, progression, and commercialization of small-molecule pharmaceutical products designed to address central nervous system (CNS) conditions. Based in Geneva, Switzerland, the firm's core research centers on identifying oral small molecule allosteric modulators that interact with G-protein coupled receptors. Its leading clinical programs feature Dipraglurant, intended for the treatment of levodopa-induced dyskinesia in Parkinson's disease and dystonia; ADX71149, targeting epilepsy and various other neurological disorders; and GABAB PAM, developed to combat addiction. Addex has established strategic licensing and collaborative partnerships with organizations including Janssen Pharmaceuticals Inc., Indivior PLC, and The Charcot–Marie–Tooth Association. Founded in 2002, the company changed its name from Addex Pharmaceuticals Ltd to its current designation in March 2012.
Részvényárfolyam
$0.05124204
Piaci kapitalizáció
$7.78M
Változás (1 nap)
0.51%
Változás (1 év)
-23.73%
Ország
CH
Kereskedés Addex Therapeutics Ltd (ADXN)

Kategória

Addex Therapeutics Ltd (ADXN) osztalékhozamának története
Addex Therapeutics Ltd (tőzsdei szimbólum: ADXN) osztalékhozama (TTM) 2026 állapot szerint: 0
Átlagos osztalékhozam az elmúlt 5 évben: 0.00%
Addex Therapeutics Ltd (ADXN) osztalékhozamainak története 2026 és 2026 között
Éves záró osztalékhozam (TTM)
Év Osztalékhozam Változtassa meg
Nincs elég adat a megadott dátumokhoz.
Hasonló cégek vagy versenytársak osztalékhozamai (TTM)